Immunitor's V5 meets TB endpoint

Immunitor Inc. (College Park, Md.) said once-daily oral V5 plus standard of care (SOC)

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE